Bergenbio Financial Statements From 2010 to 2024
| BGBIO Stock | NOK 9.98 0.39 3.76% |
Check Bergenbio ASA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bergenbio ASA's main balance sheet or income statement drivers, such as , as well as many indicators such as . Bergenbio financial statements analysis is a perfect complement when working with Bergenbio ASA Valuation or Volatility modules.
Bergenbio |
Bergenbio ASA Company Current Valuation Analysis
Bergenbio ASA's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Bergenbio ASA Current Valuation | 421.26 M |
Most of Bergenbio ASA's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bergenbio ASA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Bergenbio ASA has a Current Valuation of 421.26 M. This is 97.07% lower than that of the Biotechnology sector and 90.93% lower than that of the Health Care industry. The current valuation for all Norway stocks is 97.47% higher than that of the company.
Bergenbio ASA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bergenbio ASA's current stock value. Our valuation model uses many indicators to compare Bergenbio ASA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bergenbio ASA competition to find correlations between indicators driving Bergenbio ASA's intrinsic value. More Info.Bergenbio ASA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bergenbio ASA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bergenbio ASA's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Bergenbio ASA Financial Statements
Bergenbio ASA investors utilize fundamental indicators, such as revenue or net income, to predict how Bergenbio Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
BerGenBio ASA, a clinical-stage biopharmaceutical company, develops medicines to treat immune evasive, drug resistant, and metastatic cancers. The company was founded in 2007 and is headquartered in Bergen, Norway. BerGenBio ASA is traded on Oslo Stock Exchange in Norway.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Bergenbio Stock
Bergenbio ASA financial ratios help investors to determine whether Bergenbio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bergenbio with respect to the benefits of owning Bergenbio ASA security.